全文获取类型
收费全文 | 2283篇 |
免费 | 149篇 |
国内免费 | 184篇 |
专业分类
化学 | 1906篇 |
晶体学 | 4篇 |
力学 | 39篇 |
综合类 | 51篇 |
数学 | 129篇 |
物理学 | 487篇 |
出版年
2024年 | 4篇 |
2023年 | 42篇 |
2022年 | 174篇 |
2021年 | 123篇 |
2020年 | 141篇 |
2019年 | 152篇 |
2018年 | 93篇 |
2017年 | 129篇 |
2016年 | 123篇 |
2015年 | 63篇 |
2014年 | 91篇 |
2013年 | 135篇 |
2012年 | 87篇 |
2011年 | 90篇 |
2010年 | 94篇 |
2009年 | 111篇 |
2008年 | 88篇 |
2007年 | 116篇 |
2006年 | 100篇 |
2005年 | 87篇 |
2004年 | 78篇 |
2003年 | 82篇 |
2002年 | 81篇 |
2001年 | 55篇 |
2000年 | 47篇 |
1999年 | 45篇 |
1998年 | 35篇 |
1997年 | 29篇 |
1996年 | 22篇 |
1995年 | 36篇 |
1994年 | 14篇 |
1993年 | 10篇 |
1992年 | 10篇 |
1991年 | 9篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 6篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有2616条查询结果,搜索用时 15 毫秒
1.
Identification of metabolites of rupestonic acid in rat urine by liquid chromatography combined with electrospray ionization quadrupole time‐of‐flight tandem mass spectrometry 下载免费PDF全文
Dongyu Gu Yi Yang Qibin Chen Madina Habasi Jiangyu Zhao Haji Akber Aisa 《Biomedical chromatography : BMC》2015,29(4):595-603
Rupestonic acid, a potential anti‐influenza agent, is an important and characteristic compound in Artemisia rupestris L., a well‐known traditional Uighur medicine for the treatment of colds. In the present study, high‐performance liquid chromatography combined with electrospray ionization quadrupole time‐of‐flight tandem mass spectrometry was used to detect and identify the metabolites in rat urine after oral administration of rupestonic acid. A total of 10 metabolites were identified or partially characterized. The structure elucidations of the metabolites were performed by comparing the changes in accurate molecular masses and fragment ions with those of the parent compound. The results showed that the main metabolites of rupestonic acid in rat urine were formed by oxidation, hydrogenation and glucuronidation. A metabolism pathway was proposed for the first time based on the characterized structures. This metabolism study can provide essential information for drug discovery, design and clinical application of rupestonic acid. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献
2.
毛细管气相色谱法测定中药中有机氯农药残留量 总被引:4,自引:0,他引:4
建立了江西省两种中药中有机氯农药残留量的气相色谱分析方法。样品以丙酮提取,在NaCl存在下,以正已烷进行液—液分配,提取液用H2SO4净化,采用DB—1701毛细管柱,GC—ECD检测有机氯农药残留量。最低检测限为1.0×10-3-5.0×10-3mg/kg,添加回收率为85.7%-115.2%,应用于实际样品中有机氯农药残留量的检测,获得了较为满意结果。 相似文献
3.
4.
5.
6.
中药川白芷化学成分的研究 总被引:16,自引:0,他引:16
中药川白芷为伞形科当归属杭白芷 (Angelicadahurica (Fisch .exHoffm .)Benth .etHook .cvhang baizhiHort)的干燥根。川白芷为我国传统中药 ,主治头疼、鼻炎、癣症等疾病。现代药理实验表明白芷中所含的呋南香豆素具有平喘、降压、抗菌、解痉、光敏、活化交感系激素等多种药理作用[1] 。已有文献对白芷的化学成分进行了研究 ,发现白芷中主要含香豆素成分[2~ 4] 。四川遂宁产川白芷为道地白芷 ,其药性好 ,为进一步研究其活性成分 ,本文对遂宁产川白芷进行化学成分研究。共分离、… 相似文献
7.
Angelica pubescens and Angelica sinensis belong to the Umbelliferae family and both are used as traditional Chinese medicines. In the present study, headspace solid-phase microextraction (HS-SPME) with gas chromatography-mass spectrometry (GC-MS) was used for the analysis of the volatile constituents present in their roots. Eighty-seven compounds in Angelica pubescens and thirty-six compounds in Angelica sinensis were identified by GC-MS. Their relative contents were calculated by the peak area ratio. HS-SPME was compared to steam distillation (SD) by analyzing the volatile constituents of Angelica sinensis root. A good agreement between results obtained with both techniques was found. As a conclusion, HS-SPME is a powerful tool for determining the volatile constituents present in the TCMs. 相似文献
8.
微乳液增敏光度法测定中草药中微量硒 总被引:2,自引:1,他引:2
研究了在非离子微乳液介质中,硫氰酸盐罗丹明B 明胶体系分光光度法测定微量硒的方法。实验表明,当微乳液组成为V(OP乳化剂) +V(正戊醇) +V(正庚烷) +V(水) =1 5 0 +0 1 1+0 41 +97 98时,体系的表观摩尔吸收系数达1 3 0 1×1 0 6 L·mol- 1·cm- 1,灵敏度比在OP溶液中有显著提高,使该法成为少有的超高灵敏度测定硒的光度法之一。Se (Ⅳ)含量在0~0 0 5 μg·mL- 1范围内符合比耳定律,对0 0 2 μg·mL- 1Se(Ⅳ)平行测定1 1次,测得相对标准偏差为0 945 %。应用于中草药中微量硒的测定结果令人满意 相似文献
9.
10.
《Arabian Journal of Chemistry》2022,15(11):104272
Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL. 相似文献